Complete Tablet, Chewable
NDC Package 42507-321-63
Package Information
Complete (famotidine, calcium carbonate and magnesium hydroxide) tablets is a medication a multivitamin product used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy. This formulation utilizes a tablet, chewable delivery system. Marketed by Hyvee Inc, this product is identified by NDC 42507-321 and is authorized under FDA application ANDA077355.
Identification & Billing
- RxCUI: 283641 - famotidine 10 MG / calcium carbonate 800 MG / magnesium hydroxide 165 MG Chewable Tablet
- RxCUI: 283641 - calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG Chewable Tablet
- RxCUI: 283641 - calcium carbonate 800 MG / famotidine 10 MG / milk of magnesia 165 MG Chewable Tablet
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Histamine H2 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-2 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 42507 - Hyvee Inc
- 42507-321 - Complete
- 42507-321-63 - 25 TABLET, CHEWABLE in 1 BOTTLE
- 42507-321 - Complete
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (42507-321). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42507-321-63 identifies a specific commercial package of 25 tablet, chewable in 1 bottle of Complete Dual Action, a human over the counter drug labeled by Hyvee Inc. This tablet, chewable is formulated for oral use and contains calcium carbonate; famotidine; magnesium hydroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hyvee Inc on August 11, 2008. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is a multivitamin product used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy. Vitamins are important building blocks of the body and help keep you in good health.
How is this Hyvee Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42507032163. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.